Skip to main content

Table 2 Presence of HBsAg according to potential exposure

From: Hepatitis B infection and risk factors among children living with HIV in Yaounde, Cameroon: an integrated management

Exposure

 

N

Positivity rate of HBsAg

p- value

Preterm baby

Yes

5

0

p = 0.25

X2 = 1.3

No

78

2 (2.6%)

Feeding option

Exclusive breastfeeding

24

2 (8.3%)

p = 0.41

X2 = 1.76

Replacement feeding

18

00

Mixed feeding

41

00

Antiseptic bath at birth

Yes

21

00

p = 1

X2 = 00

No

62

2 (3.2%)

Infant anti-HBV vaccination status

Yes

50

00

p = 0.3

X2 = 1.063

No

33

02 (6.1%)

Maternal HBV status during pregnancy

Negative

08

00

p = 0.0097

X2 = 11.374

Positive

01

00

Unknown

69

02 (2.9%)

Vaccinated

05

00

Delivery mode

Normal vaginal

82

02 (2.4%)

p = 0.0018

X2 = 9.75

Caesarean section

01

00

Gravidity

Primiparous

19

00

p = 0.94

X2 = 0.005

Multiparous

64

02 (3.1%)

Maternal HAART during pregnancy

TENLAM-E

64

1 (1.5%)

p = 0.48

X2 = 2.459

Other regimens

13

1 (7.7%)

None

6

0

  1. HAART Highly Active Antiretroviral Therapy, TENLAM-E tenofovir-lamivudine-efavirenz, HBV hepatitis B virus; In bold are significant HBV prevalence